What is Thuasne?
Thuasne USA specializes in the design and manufacturing of high-quality prescription braces tailored for post-operative recovery and the management of chronic joint and muscle pain. Their comprehensive product portfolio spans various anatomical regions, including foot, ankle, knee, spine, shoulder, elbow, wrist, and thumb orthoses, alongside custom specialty devices and rehabilitation splints. The company is dedicated to serving medical professionals, distributors, and patients by providing advanced orthopedic and rehabilitation solutions, increasingly integrating digital health technologies to enhance patient care experiences and outcomes.
How much funding has Thuasne raised?
Thuasne has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Thuasne
PPP
Public-Private Partnership
What's next for Thuasne?
The recent major strategic investment signals a pivotal phase for Thuasne, likely enabling accelerated product development, market expansion, and the further integration of digital health solutions. This backing is expected to bolster their position in the competitive orthopedic device market, potentially leading to enhanced distribution networks and the introduction of innovative technologies aimed at improving patient mobility and recovery. The company's focus on both traditional bracing and digital health suggests a forward-thinking approach to comprehensive patient care.
See full Thuasne company page
